BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26778754)

  • 1. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure.
    Nagamoto Y; Takayama K; Ohashi K; Okamoto R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H
    J Hepatol; 2016 May; 64(5):1068-1075. PubMed ID: 26778754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure.
    Liu QW; Liu QY; Li JY; Wei L; Ren KK; Zhang XC; Ding T; Xiao L; Zhang WJ; Wu HY; Xin HB
    Stem Cell Res Ther; 2018 Nov; 9(1):321. PubMed ID: 30463600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
    Nagamoto Y; Takayama K; Tashiro K; Tateno C; Sakurai F; Tachibana M; Kawabata K; Ikeda K; Tanaka Y; Mizuguchi H
    Cell Transplant; 2015; 24(6):1127-38. PubMed ID: 24806294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice.
    Navarro-Alvarez N; Soto-Gutierrez A; Chen Y; Caballero-Corbalan J; Hassan W; Kobayashi S; Kondo Y; Iwamuro M; Yamamoto K; Kondo E; Tanaka N; Fox IJ; Kobayashi N
    J Hepatol; 2010 Feb; 52(2):211-9. PubMed ID: 20022655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
    Chiang CH; Wu WW; Li HY; Chien Y; Sun CC; Peng CH; Lin AT; Huang CS; Lai YH; Chiou SH; Hung SI; Chang YL; Lan YT; Liu DM; Chien CS; Huo TI; Lee SD; Wang CY
    Cell Transplant; 2015; 24(3):541-59. PubMed ID: 25668102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of human stem cell-derived hepatocytes in an animal model of acute liver failure.
    Ramanathan R; Pettinato G; Beeston JT; Lee DD; Wen X; Mangino MJ; Fisher RA
    Surgery; 2015 Aug; 158(2):349-59. PubMed ID: 26032830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine.
    Deguchi S; Takayama K; Mizuguchi H
    Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Kuo TK; Hung SP; Chuang CH; Chen CT; Shih YR; Fang SC; Yang VW; Lee OK
    Gastroenterology; 2008 Jun; 134(7):2111-21, 2121.e1-3. PubMed ID: 18455168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine.
    Takayama K; Akita N; Mimura N; Akahira R; Taniguchi Y; Ikeda M; Sakurai F; Ohara O; Morio T; Sekiguchi K; Mizuguchi H
    Hepatol Commun; 2017 Dec; 1(10):1058-1069. PubMed ID: 29404442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalable Differentiation of Human iPSCs in a Multicellular Spheroid-based 3D Culture into Hepatocyte-like Cells through Direct Wnt/β-catenin Pathway Inhibition.
    Pettinato G; Ramanathan R; Fisher RA; Mangino MJ; Zhang N; Wen X
    Sci Rep; 2016 Sep; 6():32888. PubMed ID: 27616299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of human adipose stem cell-derived hepatocyte-like cells with restricted localization to liver using acellular amniotic membrane.
    Yuan J; Li W; Huang J; Guo X; Li X; Lu X; Huang X; Zhang H
    Stem Cell Res Ther; 2015 Nov; 6():217. PubMed ID: 26541667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
    Zhang RR; Zheng YW; Li B; Tsuchida T; Ueno Y; Nie YZ; Taniguchi H
    Stem Cell Res Ther; 2015 Mar; 6(1):49. PubMed ID: 25889844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.
    Woo DH; Kim SK; Lim HJ; Heo J; Park HS; Kang GY; Kim SE; You HJ; Hoeppner DJ; Kim Y; Kwon H; Choi TH; Lee JH; Hong SH; Song KW; Ahn EK; Chenoweth JG; Tesar PJ; McKay RD; Kim JH
    Gastroenterology; 2012 Mar; 142(3):602-11. PubMed ID: 22138358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease?
    Wang H; Zhao T; Xu F; Li Y; Wu M; Zhu D; Cong X; Liu Y
    Cytotherapy; 2014 Mar; 16(3):309-18. PubMed ID: 24239106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny.
    Balasiddaiah A; Moreno D; Guembe L; Prieto J; Aldabe R
    J Physiol Biochem; 2013 Dec; 69(4):835-45. PubMed ID: 23715756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.
    Park S; In Hwang S; Kim J; Hwang S; Kang S; Yang S; Kim J; Kang W; Kim KH; Han DW; Paik YH
    Stem Cell Res Ther; 2019 Jan; 10(1):21. PubMed ID: 30635054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure.
    Moslem M; Valojerdi MR; Pournasr B; Muhammadnejad A; Baharvand H
    Cell Transplant; 2013; 22(10):1785-99. PubMed ID: 23394436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.